Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > Positive sentiment in the works
View:
Post by forhandlaren on Sep 08, 2022 12:56am

Positive sentiment in the works

I read that some investors blow of some steam here, which can be healthy from time to time - but don't get stuck in the mud!

Trust me, I know the fealing that my investments seems to be locked in this company because of false expectations that brought me there, low volume and low share price.

But sometime one need to realize that bashing will scare off new investors - the very same investors the we all rely on to propel the share price...

I think that the Abbvie deal is good enough considering upfront, milestones, royalty and manufacturing. But don't expect it to be fantastic - I save that for the upcoming anti-aging deal.

They came to the table from a weak position (in need of the deal to move the company forward, weak R+F deal), but on the other hand they had Linda Pullan in the negotiating team and Abbvie really wanted to close the deal because they knew the details if the clinical trial.

The big picture is important now. A new chapter is about to be written and the results presented within 3-4 months.

Seems like a new CEO is in the works among other various corporate developments. Announcement of anti-aging partner and start of the clinical trial. Another shot on anti-viral. Diabetes pet deal. Clarification of the new indication where I put my bets on obesity.

We should be very close to a point where everyone who wants to exit would be able to do so with a healthy profit. So let's turn the tide into a more positive sentiment!
Comment by Tickel1st on Sep 08, 2022 8:52am
This post has been removed in accordance with Community Policy
Comment by PeterG on Sep 08, 2022 11:15am
This post has been removed in accordance with Community Policy
Comment by biorun on Sep 08, 2022 11:17am
This post has been removed in accordance with Community Policy
Comment by SleepyHoward on Sep 08, 2022 11:44am
This post has been removed in accordance with Community Policy
Comment by BradlTheGerman on Sep 08, 2022 11:48am
This post has been removed in accordance with Community Policy
Comment by biorun on Sep 08, 2022 11:16am
Good synopsis forhandlaren. Thumbs up from me! There is a lot going on, and quite simply people want to wake up and see a different balance in their trading account, and many want to not longer see the ticker SBM listed in their portfolio. Maybe many here should not have invested in a scientific company in the first place due to its inherent hot/cold/unpredictable nature. And some made wrong ...more  
Comment by jimmyhorizon on Sep 09, 2022 10:32am
bashing? I only asked not to be lied to.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities